Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
FLT4/VEGFR3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for
Li Ma1, Weiyun Li1,2, Yanbo Zhang1,3
1State Key Laboratory of Cell Biology, Cas Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Abstract:
Macrophages rapidly undergo glycolytic reprogramming in response to macroautophagy/autophagy, inflammasome activation and pyroptosis for the clearance of bacteria. Identification the key molecules involved in these three events will provide critical potential therapeutic applications. Upon S. typhimurium infection, FLT4/VEGFR3 and its ligand VEGFC were inducibly expressed in macrophages, and FLT4 signaling inhibited CASP1 (caspase 1)-dependent inflammasome activation and pyroptosis but enhanced MAP1LC3/LC3 activation for elimination of the bacteria. Consistently, FLT4 mutants lacking the extracellular ligand-binding domain increased production of the proinflammatory metabolites such as succinate and lactate, and reduced antimicrobial metabolites including citrate and NAD(P)H in macrophages and liver upon infection. Mechanistically, FLT4 recruited AMP-activated protein kinase (AMPK) and phosphorylated Y247 and Y441/442 in the PRKAA/alpha subunit for AMPK activation. The AMPK agonist AICAR could rescue glycolytic reprogramming and inflammasome activation in macrophages expressing the mutant FLT4, which has potential translational application in patients carrying Flt4 mutations to prevent recurrent infections. Collectively, we have elucidated that the FLT4-AMPK module in macrophages coordinates glycolytic reprogramming, autophagy, inflammasome activation and pyroptosis to eliminate invading bacteria.Abbreviations: 3-MA: 3-methyladenine; AICAR: 5-aminoimidazole-4-carboxamide1-β-D-ribofuranoside; AMP: adenosine monophosphate; AMPK: AMP-activated protein kinase; ATP: adenosine triphosphate; BMDM: bone marrow-derived macrophage; CASP1: caspase 1; CFUs: colony-forming units; FLT4/VEGFR3: FMS-like tyrosine kinase 4; GFP: green fluorescent protein; LDH: lactate dehydrogenase; LPS: lipopolysaccharide; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; PEM: peritoneal exudate macrophage; PRKAA1/AMPKα1: protein kinase, AMP-activated, alpha 1 catalytic subunit; PYCARD/ASC: PYD and CARD domain containing; ROS: reactive oxygen species; SQSTM1/p62: sequestosome 1; TLR4: toll-like receptor 4; ULK1: unc-51 like autophagy activating kinase 1; VEGFC: vascular endothelial growth factor C; WT: wild type.
Insights
The FLT4-AMPK pathway in macrophages is crucial for bacterial clearance, coordinating autophagy and inflammasome activation. This finding offers therapeutic potential for infections linked to Flt4 mutations.
Area of Science:
- Immunology
- Cellular Metabolism
- Microbiology
Background:
- Macrophages employ glycolytic reprogramming, autophagy, inflammasome activation, and pyroptosis to clear bacterial infections.
- Understanding the molecular players governing these interconnected processes is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To elucidate the role of the FLT4 receptor tyrosine kinase and its ligand VEGFC in macrophage response to bacterial infection.
- To investigate the molecular mechanisms by which FLT4 signaling influences bacterial clearance, metabolic reprogramming, and inflammatory responses.
Main Methods:
- Investigated FLT4/VEGFR3 and VEGFC expression in macrophages during *S. typhimurium* infection.
- Analyzed the impact of FLT4 signaling on inflammasome activation (CASP1), pyroptosis, and autophagy (MAP1LC3/LC3).
- Assessed metabolic profiles (lactate, succinate, citrate, NAD(P)H) in wild-type and FLT4-mutant macrophages and livers.
- Determined the role of AMP-activated protein kinase (AMPK) in FLT4-mediated signaling and bacterial clearance.
Main Results:
- FLT4 signaling inhibited caspase 1-dependent inflammasome activation and pyroptosis while promoting autophagy for bacterial elimination.
- FLT4 mutants exhibited dysregulated glycolytic reprogramming, characterized by increased pro-inflammatory metabolites and decreased antimicrobial metabolites.
- FLT4 recruited and activated AMPK, which was essential for its protective functions against bacterial infection.
- The AMPK agonist AICAR rescued metabolic and inflammatory defects in FLT4-mutant macrophages.
Conclusions:
- The FLT4-AMPK signaling module in macrophages is a key regulator coordinating glycolytic reprogramming, autophagy, inflammasome activation, and pyroptosis for effective bacterial clearance.
- Targeting the FLT4-AMPK pathway presents a potential therapeutic avenue for managing bacterial infections, particularly in individuals with *Flt4* mutations.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply

